EIM Via the Myolex mScan as an ALS Biomarker

RecruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Amyotrophic Lateral Sclerosis
Interventions
DEVICE

Electrical Impedance Myography

EIM is an impedance-based technology in which an imperceptible, high-, multi-frequency (e.g., 1 kHz to 10 MHz) electrical current is applied across two electrodes; the resulting voltage signals are measured across two sense electrodes

Trial Locations (1)

02215

RECRUITING

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Beth Israel Deaconess Medical Center

OTHER